{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:52:07Z","timestamp":1774630327358,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"name":"U.S. Bureau of Medicine and Surgery"},{"DOI":"10.13039\/100014058","name":"BUMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014058","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Restore Core Basic Operational Med Research Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 remains a global biothreat because of new immune-evasive SARS-CoV-2 variants, heterogeneous immunity, and evolving vaccine recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study conducted in September 2024, we evaluated the adaptive immune responses in immunocompetent US active-duty personnel who completed a COVID-19 primary vaccine series but had variable subsequent vaccination and infection histories. We compared responses to 4 circulating variants (JN.1, KP.2, KP.3, LB.1) versus 2 previous dominant vaccine variants (BA.5, XBB.1.5). Analyses were performed based on timing (within or beyond 12 months from enrollment) and type of the most recent exposure, defined as either a COVID-19 vaccination or natural infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 317 participants were enrolled over 4 weeks in Japan. Significant reduction was observed in receptor binding domain- and spike-specific binding antibodies, neutralization antibodies, antibody-dependent cell cytotoxicity activity, memory B cells, and CD8+ T cells against circulating variants compared to previous variants. The reduction in humoral responses was more pronounced in those whose most recent exposure was greater than 12 months from enrollment. In contrast, cell-mediated T-cell responses were largely consistent regardless of the timing of the most recent exposure. The type of most recent exposure was not a significant factor in determining the magnitude of current immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Administration of COVID-19 boosters is likely to enhance cross-reactive humoral responses against SARS-CoV-2 circulating variants, potentially facilitating protection from infection and fewer missed work days among military populations. Ongoing surveillance is needed to inform future vaccine composition, timing of administration, and targeted populations to maximize protective benefits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag130","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:44:56Z","timestamp":1772887496000},"source":"Crossref","is-referenced-by-count":0,"title":["Informing the Value of \u201cBoosting\u201d Immunocompetent Adults based on Immune Responses Among US Service Members to SARS-CoV-2 Variants in Late 2024"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2623-6956","authenticated-orcid":false,"given":"Huy C","family":"Nguyen","sequence":"first","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Pan","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , Bethesda, Maryland ,","place":["USA"]},{"name":"Naval Medical Research Command , Diagnostics and Surveillance Department, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-0198","authenticated-orcid":false,"given":"Kerri G","family":"Lal","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , Bethesda, Maryland ,","place":["USA"]},{"name":"Walter Reed Army Institute of Research , US Military HIV Research Program, B Cell Biology, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey A","family":"Balinsky","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , Bethesda, Maryland ,","place":["USA"]},{"name":"Naval Medical Research Command , Diagnostics and Surveillance Department, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose R","family":"Garcia","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L","family":"Weir","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-2052","authenticated-orcid":false,"given":"Irina V","family":"Etobayeva","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"McCarthy","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelbert P","family":"Matanza","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0858-7117","authenticated-orcid":false,"given":"Lauren","family":"Smith","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , Bethesda, Maryland ,","place":["USA"]},{"name":"Walter Reed Army Institute of Research , US Military HIV Research Program, B Cell Biology, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[{"name":"Naval Medical Research Command , Diagnostics and Surveillance Department, Silver Spring, Maryland ,","place":["USA"]},{"name":"Leidos Holdings Inc. , Reston, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Fox","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , Bethesda, Maryland ,","place":["USA"]},{"name":"Naval Medical Research Command , Diagnostics and Surveillance Department, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , Bethesda, Maryland ,","place":["USA"]},{"name":"Naval Medical Research Command , Diagnostics and Surveillance Department, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley S","family":"Foo","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Serote","sequence":"additional","affiliation":[{"name":"Naval Medical Readiness Training Command Yokosuka , Laboratory Department, Yokosuka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly J","family":"Krebs","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research , US Military HIV Research Program, B Cell Biology, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peifang","family":"Sun","sequence":"additional","affiliation":[{"name":"Naval Medical Research Command , Diagnostics and Surveillance Department, Silver Spring, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-5917","authenticated-orcid":false,"given":"Andrew G","family":"Letizia","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit INDO PACIFIC , Science Directorate, Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026032711585268300_ofag130-B1"},{"key":"2026032711585268300_ofag130-B2"},{"key":"2026032711585268300_ofag130-B3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"key":"2026032711585268300_ofag130-B4","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/infdis\/jiaf030","article-title":"The current and future burden of long COVID in the United States","volume":"231","author":"Bartsch","year":"2025","journal-title":"J Infect Dis"},{"key":"2026032711585268300_ofag130-B5","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa2510226","article-title":"Association of 2024\u20132025 COVID-19 vaccine with COVID-19 outcomes in U.S. veterans","volume":"393","author":"Cai","year":"2025","journal-title":"N Engl J Med"},{"key":"2026032711585268300_ofag130-B6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.immuni.2022.08.008","article-title":"SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic","volume":"55","author":"Bertoletti","year":"2022","journal-title":"Immunity"},{"key":"2026032711585268300_ofag130-B7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00251-023-01294-9","article-title":"Role of T cells in severe COVID-19 disease, protection, and long-term immunity","volume":"75","author":"Hermens","year":"2023","journal-title":"Immunogenetics"},{"key":"2026032711585268300_ofag130-B8","doi-asserted-by":"crossref","first-page":"115907","DOI":"10.1016\/j.celrep.2025.115907","article-title":"Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters","volume":"44","author":"da Silva Antunes","year":"2025","journal-title":"Cell Rep"},{"key":"2026032711585268300_ofag130-B9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMp2213920","article-title":"Facing the new COVID-19 reality","volume":"388","author":"El-Sadr","year":"2023","journal-title":"N Engl J Med"},{"key":"2026032711585268300_ofag130-B10","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMsb2506929","article-title":"An evidence-based approach to COVID-19 vaccination","volume":"392","author":"Prasad","year":"2025","journal-title":"N Engl J Med"},{"key":"2026032711585268300_ofag130-B11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/EDE.0000000000001523","article-title":"SARS-CoV-2 outbreak dynamics in an isolated US military recruit training center with rigorous prevention measures","volume":"33","author":"Lizewski","year":"2022","journal-title":"Epidemiology"},{"key":"2026032711585268300_ofag130-B12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/infdis\/jiae249","article-title":"Informing the need for a SARS-CoV-2 booster based on the immune responses among young healthy adults to variants circulating in late 2023","volume":"230","author":"Nguyen","year":"2024","journal-title":"J Infect Dis"},{"key":"2026032711585268300_ofag130-B13","first-page":"100909","article-title":"Clinical and functional assessment of SARS-CoV-2 sequelae among young marines - a panel study","volume":"39","author":"Porter","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"2026032711585268300_ofag130-B14"},{"key":"2026032711585268300_ofag130-B15"},{"key":"2026032711585268300_ofag130-B16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"2026032711585268300_ofag130-B17","doi-asserted-by":"crossref","first-page":"576622","DOI":"10.3389\/fimmu.2020.576622","article-title":"The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens","volume":"11","author":"Duan","year":"2020","journal-title":"Front Immunol"},{"key":"2026032711585268300_ofag130-B18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/infdis\/jiad054","article-title":"Antibody responses to the SARS-CoV-2 ancestral strain and omicron variants in moderna mRNA-1273 vaccinated active-duty US Navy sailors and marines","volume":"228","author":"Sun","year":"2023","journal-title":"J Infect Dis"},{"key":"2026032711585268300_ofag130-B19","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"2026032711585268300_ofag130-B20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"2026032711585268300_ofag130-B21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-0716-2111-0_21","article-title":"Pseudovirus-based assays for the measurement of antibody-mediated neutralization of SARS-CoV-2","volume":"2452","author":"Balinsky","year":"2022","journal-title":"Methods Mol Biol"},{"key":"2026032711585268300_ofag130-B22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3201\/eid2902.221422","article-title":"Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection","volume":"29","author":"Khoury","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2026032711585268300_ofag130-B23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from alpha to omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"2026032711585268300_ofag130-B24","doi-asserted-by":"crossref","first-page":"1266829","DOI":"10.3389\/fimmu.2023.1266829","article-title":"Antibodies to S2 domain of SARS-CoV-2 spike protein in moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1","volume":"14","author":"Balinsky","year":"2023","journal-title":"Front Immunol"},{"key":"2026032711585268300_ofag130-B25","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1002\/mco2.675","article-title":"The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies","volume":"5","author":"Lu","year":"2024","journal-title":"MedComm (2020)"},{"key":"2026032711585268300_ofag130-B26","doi-asserted-by":"crossref","first-page":"e0046425","DOI":"10.1128\/mbio.00464-25","article-title":"Neutralization and stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 subvariants","volume":"16","author":"Li","year":"2025","journal-title":"mBio"},{"key":"2026032711585268300_ofag130-B27","doi-asserted-by":"crossref","first-page":"2406300","DOI":"10.1080\/22221751.2024.2406300","article-title":"Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies","volume":"13","author":"Jiang","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"2026032711585268300_ofag130-B28","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2666-5247(23)00012-5","article-title":"Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study","volume":"4","author":"Regev-Yochay","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026032711585268300_ofag130-B29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/vaccines12050471","article-title":"High concentration of anti-SARS-CoV-2 antibodies 2 years after COVID-19 vaccination stems not only from boosters but also from widespread, often unrecognized, contact with the virus","volume":"12","author":"Swad\u017aba","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026032711585268300_ofag130-B30","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1038\/s41598-024-55245-9","article-title":"Longitudinal antibody dynamics after COVID-19 vaccine boosters based on prior infection status and booster doses","volume":"14","author":"Matsumoto","year":"2024","journal-title":"Sci Rep"},{"key":"2026032711585268300_ofag130-B31","doi-asserted-by":"crossref","first-page":"e70521","DOI":"10.1002\/jmv.70521","article-title":"Modeling antibody kinetics post-mRNA booster vaccination and protection durations against SARS-CoV-2 infection","volume":"97","author":"Ponce","year":"2025","journal-title":"J Med Virol"},{"key":"2026032711585268300_ofag130-B32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.immuni.2024.02.016","article-title":"Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans","volume":"57","author":"Tortorici","year":"2024","journal-title":"Immunity"},{"key":"2026032711585268300_ofag130-B33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-023-06753-7","article-title":"Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting","volume":"625","author":"Yisimayi","year":"2024","journal-title":"Nature"},{"key":"2026032711585268300_ofag130-B34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chom.2023.12.003","article-title":"Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant","volume":"32","author":"Nesamari","year":"2024","journal-title":"Cell Host Microbe"},{"key":"2026032711585268300_ofag130-B35","doi-asserted-by":"crossref","first-page":"eabj6824","DOI":"10.1126\/scitranslmed.abj6824","article-title":"Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity","volume":"14","author":"Riou","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026032711585268300_ofag130-B36","doi-asserted-by":"crossref","first-page":"eabo1303","DOI":"10.1126\/sciimmunol.abo1303","article-title":"Understanding T cell responses to COVID-19 is essential for informing public health strategies","volume":"7","author":"Vardhana","year":"2022","journal-title":"Sci Immunol"},{"key":"2026032711585268300_ofag130-B37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-immunol-101721-061120","article-title":"T cell responses to SARS-CoV-2","volume":"41","author":"Sette","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"2026032711585268300_ofag130-B38","doi-asserted-by":"crossref","first-page":"e167955","DOI":"10.1172\/JCI167955","article-title":"Durability of immune responses to mRNA booster vaccination against COVID-19","volume":"133","author":"Arunachalam","year":"2023","journal-title":"J Clin Invest"},{"key":"2026032711585268300_ofag130-B39","doi-asserted-by":"crossref","first-page":"100562","DOI":"10.1016\/j.xcrm.2022.100562","article-title":"Count on US: T cells in SARS-CoV-2 infection and vaccination","volume":"3","author":"Kedzierska","year":"2022","journal-title":"Cell Rep Med"},{"key":"2026032711585268300_ofag130-B40","doi-asserted-by":"crossref","first-page":"126993","DOI":"10.1016\/j.micres.2022.126993","article-title":"Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies","volume":"258","author":"Xiang","year":"2022","journal-title":"Microbiol Res"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag130\/67300944\/ofag130.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/3\/ofag130\/67300944\/ofag130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/3\/ofag130\/67300944\/ofag130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:59:02Z","timestamp":1774627142000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag130\/8514297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag130","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]},"article-number":"ofag130"}}